Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT
Allogeneic hematopoietic cell transplantation is the standard treatment of acute myeloid leukemia, but many patients relapse. Here the authors show increased markers of exhaustion and cancer antigen specificity within bone marrow-residing memory T cells precede and potentially predict the relapse.
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-03-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-08871-1 |